Dudediligence.

Becton, Dickinson and Company

BDXNYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$5.44BSep ’24$5.17BDec ’24$4.48BMar ’25$5.51BJun ’25$5.89BSep ’25$5.25BDec ’25$4.71BMar ’26$4.98BJun ’26
Net income, by quarter
$400.0MSep ’24$303.0MDec ’24$308.0MMar ’25$574.0MJun ’25$493.0MSep ’25$382.0MDec ’25−$311.0MMar ’26$377.0MJun ’26
Fiscal years, by the month each ended
LineSep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Revenue$19.13B$18.87B$19.37B$20.18B$21.84B
Gross profit$8.63B$8.48B$8.17B$9.13B$9.93B
Operating income$2.25B$2.28B$2.11B$2.40B$2.58B
Net income$2.09B$1.78B$1.48B$1.71B$1.68B
Operating cash flow$4.13B$2.47B$2.99B$3.84B$3.43B
Free cash flow$2.93B$1.50B$2.12B$3.12B$2.67B
Cash$2.28B$1.01B$1.42B$1.72B$567.0M
Debt$17.61B$16.07B$15.88B$20.11B$19.18B
Shares outstanding364.6M364.6M370.6M370.6M370.6M